Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?
Spremljeno u:
| Izdano u: | PLoS Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PLOS
2004
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC529422/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15578104/ https://ncbi.nlm.nih.govhttps://doi.org/10.1371/journal.pmed.0010026 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|